4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-001301
CHIEF OPERATING OFFICER sold 28,367 shares at an average $24.18 ($685,868)
- CHIEF OPERATING OFFICER acquired 21,700 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Anish · CHIEF OPERATING OFFICER
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,700 | $1.12 | $11,984 | 10,700 | D |
| 2025-01-07 | Exercise or conversion : show line 2 in the form 10b5-1 | +2,000 | $2.48 | $4,960 | 12,700 | D |
| 2025-01-07 | Exercise or conversion : show line 3 in the form 10b5-1 | +9,000 | $2.48 | $22,320 | 21,700 | D |
| 2025-01-07 | Sale : show line 4 in the form 10b5-1 | −20,260 | $24.15 | $489,330 | 1,440 | D |
| 2025-01-07 | Sale : show line 5 in the form 10b5-1 | −1,440 | $24.56 | $35,368 | 0 | D |
| 2025-01-07 | Sale : show line 6 in the form 10b5-1 | −6,577 | $24.17 | $158,957 | 336,734 | I |
| 2025-01-07 | Sale : show line 7 in the form 10b5-1 | −90 | $24.60 | $2,214 | 336,644 | I |
| Open-market sales · 28,367 sh · avg $24.18 · $685,868 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-07 | Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (right to buy) | −10,700 | 67 | D |
| 2025-01-07 | Exercise or conversion : show line 9 in the form 10b5-1 Employee Stock Option (right to buy) | −2,000 | 827 | D |
| 2025-01-07 | Exercise or conversion : show line 10 in the form 10b5-1 Employee Stock Option (right to buy) | −9,000 | 44,342 | D |
Loading xslF345X05/form4-01102025_100148.xml…